The EMBO Journal
 
Advanced search
Journal home
Aims and scope
Current issue
Advance Online Publication
Web Focuses
Archive:-
Browse by issue
Browse by subject
Browse by category
Free online sample issue
Press releases
Authors & Referees
Editorial process
Guide for authors
Submit an article
Guide for referees
Editorial Team, Senior Advisors and Advisory Editorial Board
Contact Editorial office
Customer services
Subscribe
Order sample copy
Purchase articles
Reprints and permissions
Contact NPG
Advertising
EMBO
www.embo.org
Article
Subject Categories: Differentiation & Death | Molecular Biology of Disease
The EMBO Journal (2007) 26, 4523–4534, doi:10.1038/sj.emboj.7601872
Published online 11 October 2007
The pro-apoptotic kinase Mst1 and its caspase cleavage products are direct inhibitors of Akt1
Bekir Cinar1, 2, Ping-Ke Fang1, 2, Mohini Lutchman1, 2, Dolores Di Vizio1, 2, Rosalyn M Adam1, 2, Natalya Pavlova3, Mark A Rubin4, Pamela C Yelick5, 6 and Michael R Freeman1, 2, 3
1 Urological Diseases Research Center, Department of Urology, Children's Hospital Boston, Boston, MA, USA
2 Department of Surgery, Harvard Medical School, Boston, MA, USA
3 Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA
4 Department of Pathology, Brigham and Women's Hospital, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
5 Division of Craniofacial and Molecular Genetics, Department of Oral and Maxillofacial Pathology, Tufts University, Boston, MA, USA
6 Division of Craniofacial and Molecular Genetics, Department of Biomedical Engineering, Tufts University, Boston, MA, USA

To whom correspondence should be addressed
Michael R Freeman, Enders Research Laboratories, Department of Urology, Children's Hospital Boston, suite 1161, 300 Longwood Avenue, Boston, MA 02115, USA. Tel.: +1 617 919 2644; Fax: +1 617 730 0238; E-mail: michael.freeman@childrens.harvard.edu

Received 20 December 2006; Accepted 10 September 2007; Published online 11 October 2007.
Abstract
Akt kinases mediate cell growth and survival. Here, we report that a pro-apoptotic kinase, Mst1/STK4, is a physiological Akt1 interaction partner. Mst1 was identified as a component of an Akt1 multiprotein complex isolated from lipid raft-enriched fractions of LNCaP human prostate cancer cells. Endogenous Mst1, along with its paralog, Mst2, acted as inhibitors of endogenous Akt1. Surprisingly, mature Mst1 as well as both of its caspase cleavage products, which localize to distinct subcellular compartments and are not structurally homologous, complexed with and inhibited Akt1. cRNAs encoding full-length Mst1, and N- and C-terminal caspase Mst1 cleavage products, reverted an early lethal phenotype in zebrafish development induced by expression of membrane-targeted Akt1. Mst1 and Akt1 localized to identical subcellular sites in human prostate tumors. Mst1 levels declined with progression from clinically localized to hormone refractory disease, coinciding with an increase in Akt activation with transition from hormone naïve to hormone-resistant metastases. These results position Mst1/2 within a novel branch of the phosphoinositide 3-kinase/Akt pathway and suggest an important role in cancer progression.
Keywords: apoptosis, kinases, lipid rafts, prostate cancer, protein complex
Send to a friendEmail link to a friend
PDFDownload PDF
Full textFull text
Next article
Previous article
Table of contents
rights and permissionsRights and permissions
order commercial reprintsReprints
ToC alertRegister for table of contents by email
  Privacy policy Copyright © 2007 by the European Molecular Biology Organization